How Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP
Hannah Brown, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Tushita Mayanil, MBBS (MD)
Melanie Yabs, PharmD, MS, BCPP
Digital Danger: Understanding AI Psychosis in Schizophrenia
Ragy R. Girgis, MD, MS
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Nicholas Whipple, MD, MPH
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Desiree Matthews, PMHNP-BC
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
Ashvini Keshavan, MRCP, PhD
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Sharon Sha, MD, MS
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Matcheri S. Keshavan, MD
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Caterina Garone, MD, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.